Abstract:Abstract Introduction Neuropathic pain (NP) is a poorly studied but common complaint of burn survivors and severely limits patients in regard to quality of life and function well after their burn injury. Currently, there is a paucity of data on the association between NP and its sequelae with burn survivors in the literature. As such, the purpose of this study is to better understand the incidence of NP and associated factors on a national scale using the Burn Model System (BMS) National Database. Methods The BMS National Database was queried to identify burn patients responding to the primary outcome measure: numbness, pins and needles or burning sensations in three locations – (see Table 1) at enrollment, six months, 12 months, two years, and five years. The data were analyzed to determine the percent of the population reporting NP. Further subgroup analyses examined demographic and clinical characteristics associated with NP. Statistical analysis included non-parametric tests, Chi-square or Fisher’s exact, and regression analysis. Results A total of 915 patients at discharge were included in analysis. At discharge, two-thirds of patients (66.5%, n=608) experienced NP, with over half still reporting NP at 5-year follow-up (Table 1). Patients with NP had significantly higher PROMIS-29 pain interference and itch scores at all time points after six months. NP patients had significantly higher anxiety, depression, and sleep disturbance PROMIS-29 scores and were significantly less able to participate in social roles at all follow-up points (Figure 1). Multiple logistic regression demonstrated male sex, %TBSA burn size, and moderate-to-severe pain on a zero to ten pain scale to be significant predictors of NP at 6-month follow-up (M sex: OR 1.9, p=0.042; %TBSA: OR 1.03, p=.009; moderate-to-severe pain: OR 5.4, p< 0.001). At 12-month follow-up, %TBSA burn size and moderate-to-severe pain were found to be significantly predictive of NP (%TBSA: OR: 1.03, p=.002; moderate-to-severe-pain: OR: 4.13, p=0.002). At 24-month follow-up, ethnicity, and employment status were significant predictors of NP (ethnicity: OR 3.1, p=0.033; employment status OR 3.0, p=0.016). Conclusions The present study highlights the significant prevalence of NP in burn patients and the detrimental impacts on their physical, psychological, and social outcomes. The findings emphasize the importance of certain risk factors in NP and their role in enabling providers to provide more pointed and critical intervention. Moreover, the study supports a collaborative and comprehensive approach to treatment that accounts for the multifactorial nature of NP. Applicability of Research to Practice The study emphasizes the importance of identifying specific risk factors to enable targeted interventions in clinical practice. A collaborative and comprehensive treatment approach that addresses both physical symptoms and psychosocial factors is crucial for improving long-term outcomes in burn patients with NP.

Platelet-Rich Plasma Injection in Burn Scar Areas Alleviates Neuropathic Scar Pain

Pulsed Radiofrequency to the Dorsal Root Ganglion or the Sciatic Nerve Reduces Neuropathic Pain Behavior, Decreases Peripheral Pro-Inflammatory Cytokines and Spinal Β-Catenin in Chronic Constriction Injury Rats

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Platelet-rich plasma in umbilical cord blood reduces neuropathic pain in spinal cord injury by altering the expression of ATP receptors

Therapeutic role of mesenchymal stem cells and platelet-rich plasma on skin burn healing and rejuvenation: A focus on scar regulation, oxido-inflammatory stress and apoptotic mechanisms

Considerations on the Use of Platelet-Rich Plasma, Specifically for Burn Treatment

Evaluation of the efficacy, safety and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid and the combination of platelet-rich plasma and non-cross-linked hyaluronic acid in patients with burn scars treated with fractional CO2 laser: A randomized controlled clinical trial

Dose-Dependent Effect of Hyperbaric Oxygen Treatment on Burn-Induced Neuropathic Pain in Rats

The Role of Platelet-Rich Plasma in Reducing Pain, Pruritus, and Improving Wound Healing of Skin Graft Donor Site

Efficacy of Lyophilised Platelet-Rich Plasma Powder on Healing Rate in Patients With Deep Second Degree Burn Injury: A Prospective Double-Blind Randomized Clinical Trial

Study of Novel Platelet Lysate Film-Forming Spray on Burn Wounds in Rats

711 Neuropathic Pain in Burn Patients - A Common Problem with Little Literature: A Systematic Review

Effect of extracorporeal shock wave therapy on scar pain in burn patients: A prospective, randomized, single-blind, placebo-controlled study

Effectiveness of platelet derivatives in neuropathic pain management: A systematic review

Early Hyperbaric Oxygen Treatment Attenuates Burn-Induced Neuroinflammation by Inhibiting the Galectin-3-Dependent Toll-Like Receptor-4 Pathway in a Rat Model

Fat Grafting and Regenerative Medicine in Burn Care

Application of Auriculotherapy for Post-Burn Scar Syndrome in Young Adults with Major Burns

Clinical efficacy of ultrasound-guided chondroitin polysulfate from bovine trachea combined with fractional CO2 laser in the treatment of scar after burn repair

Anti-Allodynic Effects of Polydeoxyribonucleotide in an Animal Model of Neuropathic Pain and Complex Regional Pain Syndrome

89 Neuropathic Pain After Burn Injury: A Severe but Common Problem in Recovery

Feasibility of Platelet Rich Plasma Use in Hair Transplantation in Treatment of Post Burn Scar